Major depressive disorder Trials in Cincinnati, United States
Conditions / Major depressive disorder / Cincinnati, United States
Clinical trials for Major depressive disorder investigate a range of treatment strategies and patient populations.
77 total trials for this combination
Showing top 10 of 77 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04039022 | Open-Label Safety Study of AXS-05 in Subjects With Depression | COMPLETED | PHASE3 |
| NCT01436175 | SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study | TERMINATED | PHASE3 |
| NCT00278941 | Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01157078 | A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD) | COMPLETED | PHASE3 |
| NCT00006286 | Treatment for Adolescents With Depression Study (TADS) | COMPLETED | PHASE3 |
| NCT04019704 | A Trial of AXS-05 in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01153347 | A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT00692445 | TC-5214 as add-on the Treatment of Major Depressive Disorder | COMPLETED | PHASE2 |
| NCT04855747 | A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) | TERMINATED | PHASE3 |
| NCT06705478 | Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV | NOT_YET_RECRUITING | PHASE2 |